Thiogenesis Therapeutics Corp TTIPF
Trading Information
- Previous Close Price
- $0.42
- Day Range
- $0.41–0.42
- 52-Week Range
- $0.36–0.58
- Bid/Ask
- $0.37 / $0.51
- Shares Outstanding
- 69.98M
- Market Cap
- $21.77M
- Volume/Avg
- 200 / 8,367
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Thiogenesis Therapeutics Corp is a clinical-stage biotechnology company developing TTI-0102, a novel controlled-release cysteamine prodrug designed to improve tolerability and dosing relative to existing therapies. The Company is focused on TTI-0102 in nephropathic cystinosis, where it is in late-stage development, and is also conducting research and clinical development activities for primary mitochondrial diseases, including Leigh syndrome spectrum disorders.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.thiogenesis.com
Valuation
|
Metric
|
TTIPF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 6.21 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
TTIPF
|
|---|---|
Quick Ratio | 10.69 |
Current Ratio | 10.81 |
Interest Coverage | — |
Quick Ratio
TTIPF
Profitability
|
Metric
|
TTIPF
|
|---|---|
Return on Assets (Normalized) | −186.26% |
Return on Equity (Normalized) | −304.34% |
Return on Invested Capital (Normalized) | −305.02% |
Return on Assets
TTIPF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|<tRs^$ | LOCK|Gl#s& | $138B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|JQ<@v#q | LOCK|zn>% | $85B | |||
| argenx SE ADR
ARGX
| LOCK|p%Pw^rq | LOCK|Jq | $65B | |||
| Moderna Inc
MRNA
| LOCK|>Y<Dk?# | LOCK|&?X | $58B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|G@Zf#q | LOCK|Pl> | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|gB>x?#b | LOCK|j&d& | $36B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|y^@zZt$D | LOCK|R%%g | $28B | |||
| BioNTech SE ADR
BNTX
| LOCK|bsv@KYr | LOCK|@k | $26B | |||
| Incyte Corp
INCY
| LOCK|&%$^h%v | LOCK|f>r | $26B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|vlySMpv | LOCK|N> | $16B |
United States